登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRixv，3月3日，Systematic Review of the Registered Clinical Trials of Coronavirus Diseases 2019 (COVID-19)》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-04

  • Systematic Review of the Registered Clinical Trials of Coronavirus Diseases 2019 (COVID-19)

    Rui-fang Zhu, Ru-lu Gao, Sue-Ho Robert, Jin-ping Gao, Shi-gui Yang, Changtai Zhu

    doi: https://doi.org/10.1101/2020.03.01.20029611

    Abstract

    Background: Since the outbreak of coronavirus diseases 2019 (COVID-19), many researchers in China have immediately carried out clinical research scheme of the COVID-19. But, there is still a lack of systematic review of registered clinical trials. Therefore, we made the first systematic review of the clinical trials of COVID-19 in order to provide evidence for the control of the COVID-19.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.03.01.20029611v1
15浏览量
原文链接
相关报告

  • 《MedRxiv，3月10日，Clinical Characteristics of 2019 Coronavirus Pneumonia (COVID-19): An Updated Systematic Review》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-11
    • Clinical Characteristics of 2019 Coronavirus Pneumonia (COVID-19): An Updated Systematic Review Zhangfu Fang, Fang Yi, Kang Wu, Kefang Lai, Xizhuo Sun, Nanshan Zhong, Zhigang Liu doi: https://doi.org/10.1101/2020.03.07.20032573 Abstract OBJECTIVE Clinical characteristics of novel coronavirus pneumonia (COVID-19) have been described in numerous studies but yielded varying results. We aimed to conduct a systematic review on scientific literatures and to synthesize critical data on clinical traits of COVID-19 from its initial outbreak to pandemic. METHODS Systematic searches were conducted to identify retrospective observational study that contained clinical characteristics on COVID-19 through multiple databases. Two reviewers independently evaluated eligible publications. Data on clinical characteristics of COVID-19 were extracted and analyzed. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    164浏览量
    原文链接

  • 《MedRxiv，3月8日，Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-09
    • Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review Ruijin Qiu, Xuxu Wei, Mengzhu Zhao, Changming Zhong, Chen Zhao, Jiayuan Hu, Min Li, Ya Huang, Songjie Han, Tianmai He, Jing Chen, Hongcai Shang doi: https://doi.org/10.1101/2020.03.04.20031401 Abstract Objectives: To examine heterogeneity of outcomes in protocols of clinical trials of Coronavirus Disease 2019 (COVID-19) and to identify outcomes for prioritization in developing a core outcome set (COS) in this field. Design: This study is a review. Data sources: Databases of ICMJE-accepted clinical trial registry platform were searched on February 14, 2020. Eligibility Criteria: Randomized controlled trials (RCTs) and non-RCTs of COVID-19 were considered.Conditions of patients include common type, severe type or critical type. Interventions include traditional Chinese medicine (TCM) and Western medicine. We excluded trials that for discharged patients, psychological intervention and complications of COVID-19. Data extraction and synthesis: The general information and outcomes, outcome measurement instruments and measurement times were extracted. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    104浏览量
    原文链接